© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Globus Medical, Inc. (GMED) shows an Average True Range (ATR) of 2.72 and an Enterprise Value of 7.02B. Its average trading volume over the past 3 months is 1.71M, indicating liquidity. These fundamental metrics provide insight into GMED's underlying financial health and market activity.
| ATR | 2.72 |
| Enterprise Value | 7.02B |
| Avg Vol (3 Months) | 1.71M |
| Avg Vol (10 Days) | 1.29M |
Globus Medical, Inc. (GMED) technical indicators as of February 6, 2026: the SMA 20 is -4.6%, SMA 50 at -2.66%, and SMA 200 at 27.36%. The RSI 14 value is 41.31, suggesting its current momentum. These technical analysis signals help assess GMED's price trends and potential future movements.
| SMA 20 | -4.6% |
| SMA 50 | -2.66% |
| SMA 200 | 27.36% |
| RSI 14 | 41.31 |
Globus Medical, Inc. (GMED) stock performance overview as of February 6, 2026: The 52-week high is $101.4 (currently -13.71% below), and the 52-week low is $51.79 (currently 68.95% above). Over the past year, GMED's performance is 2.74%, compared to the S&P 500's 8.96% change.
| 52-Week High | 101.4 |
| 52-Week High Chg | -13.71% |
| 52-Week Low | 51.79 |
| 52-Week Low Chg | +68.95% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Globus Medical, Inc. (GMED) stock's recent performance metrics show that over the last month, GMED is 9.28%, with a Year-to-Date (YTD) performance of 6.46%. Over the past year, the stock has seen a 2.74% change. These figures summarize GMED's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 93.63 | 101.4 | 101.4 | 101.4 | 101.4 | 101.4 |
| Low | 86.01 | 86.01 | 60.26 | 52.68 | 51.79 | 85.65 |
| Performance | +1.34% | +9.28% | +56.01% | +79.13% | +2.74% | +6.46% |
According to current financial data, GMED stock's P/E (TTM) ratio is 27.84, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for GMED, including P/S (4.24), P/B (2.68), and P/FCF (20.25), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GMED | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 27.84 | -1.23 | -26.18 | 32.59 |
| P/S (TTM) | 4.24 | 3.71 | 14.12 | 5.98 |
| P/B (TTM) | 2.68 | -6.68 | -0.58 | 5.45 |
| P/FCF (TTM) | 20.25 | -183.06 | -751.52 | 31.94 |